East Brunswick, NJ, United States of America

Ke Chen

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 11.9

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2014-2021

where 'Filed Patents' based on already Granted Patents

9 patents (USPTO):

Title: The Innovative Contributions of Inventor Ke Chen

Introduction

Ke Chen is a distinguished inventor based in East Brunswick, NJ, USA, known for his significant contributions to the field of pharmaceuticals. With a commendable portfolio of 9 patents to his name, Chen has demonstrated a consistent ability to innovate and improve upon existing processes and compounds in the pharmaceutical industry.

Latest Patents

Among his latest inventions is a groundbreaking process for synthesizing 6-(cyclopropaneamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-N-(methyl-d3)pyridazine-3-carboxamide. This invention relates to an improved method for the preparation of a compound that is currently undergoing clinical trials for the treatment of auto-immune and auto-inflammatory diseases, including psoriasis. Additionally, he has developed methods for the preparation of an HIV attachment inhibitor piperazine prodrug compound, showcasing his versatility and relevance in addressing critical health issues.

Career Highlights

Ke Chen's career is marked by his tenure at Bristol-Myers Squibb Company, where he has contributed to numerous innovative projects and research initiatives. His work has not only advanced the company's portfolio but has also significantly impacted the medicinal chemistry landscape.

Collaborations

Working alongside talented colleagues such as Martin D. Eastgate and Michael S. Bultman, Chen has engaged in dynamic collaborations that enhance the creative process and promote the development of novel therapeutic solutions. These partnerships reflect the collaborative spirit essential for innovation in the ever-evolving pharmaceutical field.

Conclusion

Ke Chen stands out as a prominent inventor whose work exemplifies innovation in the pharmaceutical sector. With his recent patents and collaborative efforts, he continues to pave the way for advancements that address critical health challenges. His contributions are a testament to the power of ingenuity and the relentless pursuit of improved therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…